- Home
- IMUX vs ORGN Comparison
IMUX vs ORGN Comparison
Compare IMUX & ORGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMUX
- ORGN
- Stock Information
- Founded
- IMUX 2016
- ORGN 2008
- Country
- IMUX United States
- ORGN United States
- Employees
- IMUX N/A
- ORGN N/A
- Industry
- IMUX Biotechnology: Pharmaceutical Preparations
- ORGN Major Chemicals
- Sector
- IMUX Health Care
- ORGN Industrials
- Exchange
- IMUX Nasdaq
- ORGN Nasdaq
- Market Cap
- IMUX 94.9M
- ORGN 96.4M
- IPO Year
- IMUX N/A
- ORGN N/A
- Fundamental
- Price
- IMUX $1.01
- ORGN $0.67
- Analyst Decision
- IMUX Strong Buy
- ORGN Strong Buy
- Analyst Count
- IMUX 6
- ORGN 1
- Target Price
- IMUX $13.20
- ORGN $3.00
- AVG Volume (30 Days)
- IMUX 1.3M
- ORGN 736.4K
- Earning Date
- IMUX 05-20-2025
- ORGN 05-15-2025
- Dividend Yield
- IMUX N/A
- ORGN N/A
- EPS Growth
- IMUX N/A
- ORGN N/A
- EPS
- IMUX N/A
- ORGN N/A
- Revenue
- IMUX N/A
- ORGN $31,282,000.00
- Revenue This Year
- IMUX N/A
- ORGN $49.18
- Revenue Next Year
- IMUX N/A
- ORGN $144.81
- P/E Ratio
- IMUX N/A
- ORGN N/A
- Revenue Growth
- IMUX N/A
- ORGN 8.60
- 52 Week Low
- IMUX $0.83
- ORGN $0.42
- 52 Week High
- IMUX $2.11
- ORGN $1.90
- Technical
- Relative Strength Index (RSI)
- IMUX 46.64
- ORGN 47.17
- Support Level
- IMUX $0.95
- ORGN $0.64
- Resistance Level
- IMUX $1.22
- ORGN $0.71
- Average True Range (ATR)
- IMUX 0.12
- ORGN 0.06
- MACD
- IMUX -0.01
- ORGN 0.00
- Stochastic Oscillator
- IMUX 16.67
- ORGN 16.65
About IMUX Immunic Inc.
Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.
About ORGN Origin Materials Inc.
Origin Materials Inc is a carbon-negative materials company. The platform turns the carbon found in biomass into useful materials, while eliminating the need for fossil resources and capturing carbon in the process. Its products include, PET circular caps and closures, Para-xylene, carbon black, Levulinic acid among others by using materials like food and beverage packaging, clothing, textiles, plastics, car parts, carpeting, tires, adhesives, soil amendments, and fuels.